SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
19 05 2021
Historique:
received: 16 04 2021
revised: 12 05 2021
accepted: 15 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 2 7 2021
Statut: epublish

Résumé

Understanding the ecological and epidemiological roles of pets in the transmission of SARS-CoV-2 is critical for animal and human health, identifying household reservoirs, and predicting the potential enzootic maintenance of the virus. We conducted a longitudinal household transmission study of 76 dogs and cats living with at least one SARS-CoV-2-infected human in Texas and found that 17 pets from 25.6% of 39 households met the national case definition for SARS-CoV-2 infections in animals. This includes three out of seventeen (17.6%) cats and one out of fifty-nine (1.7%) dogs that were positive by RT-PCR and sequencing, with the virus successfully isolated from the respiratory swabs of one cat and one dog. Whole-genome sequences of SARS-CoV-2 obtained from all four PCR-positive animals were unique variants grouping with genomes circulating among people with COVID-19 in Texas. Re-sampling showed persistence of viral RNA for at least 25 d-post initial test. Additionally, seven out of sixteen (43.8%) cats and seven out of fifty-nine (11.9%) dogs harbored SARS-CoV-2 neutralizing antibodies upon initial sampling, with relatively stable or increasing titers over the 2-3 months of follow-up and no evidence of seroreversion. The majority (82.4%) of infected pets were asymptomatic. 'Reverse zoonotic' transmission of SARS-CoV-2 from infected people to animals may occur more frequently than recognized.

Identifiants

pubmed: 34069453
pii: v13050938
doi: 10.3390/v13050938
pmc: PMC8159091
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CDC HHS
ID : RFP 75D 301-20-R-68167
Pays : United States
Organisme : Texas A&M AgriLife Research
ID : NA
Organisme : NIAID NIH HHS
ID : K01 AI128005
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

Emerg Infect Dis. 2020 Dec;26(12):3069-3071
pubmed: 32788033
Vet Pathol. 2020 Sep;57(5):653-657
pubmed: 32663073
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):710-713
pubmed: 32525853
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Emerg Infect Dis. 2021 Apr;27(4):1015-1022
pubmed: 33770472
EBioMedicine. 2021 Feb;64:103230
pubmed: 33530000
J Gen Virol. 2003 Oct;84(Pt 10):2735-2744
pubmed: 13679608
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Emerg Infect Dis. 2020 Dec;26(12):3071-3074
pubmed: 32938527
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
BMC Genomics. 2016 Sep 05;17:708
pubmed: 27595578
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):244-250
pubmed: 32362649
Emerg Infect Dis. 2021 May 12;27(7):
pubmed: 33979566
Microbiol Resour Announc. 2020 May 28;9(22):
pubmed: 32467283
Nat Commun. 2020 Dec 4;11(1):6231
pubmed: 33277505
Emerg Microbes Infect. 2020 Dec;9(1):2322-2332
pubmed: 33028154
Viruses. 2021 Feb 23;13(2):
pubmed: 33672217
mBio. 2020 Oct 13;11(5):
pubmed: 33051368
Emerg Microbes Infect. 2020 Dec;9(1):2013-2019
pubmed: 32867625
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
J Virol Methods. 2018 Jun;256:116-122
pubmed: 29499225
Vet Rec. 2014 Jan 25;174(4):85-91
pubmed: 24464377
One Health. 2020 Dec;10:100164
pubmed: 32904469
Transbound Emerg Dis. 2020 Nov;67(6):2324-2328
pubmed: 32500944
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
Curr Biol. 2020 Jun 8;30(11):2196-2203.e3
pubmed: 32416074
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156330
Transbound Emerg Dis. 2020 Jul;67(4):1745-1749
pubmed: 32303108

Auteurs

Sarah A Hamer (SA)

College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.

Alex Pauvolid-Corrêa (A)

College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
Laboratory of Respiratory Viruses and Measles, SARS-CoV-2 National Reference Laboratory and Regional Reference Laboratory in the Americas (PAHO/WHO), Fiocruz, Rio de Janeiro 21040-360, Brazil.

Italo B Zecca (IB)

College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.

Edward Davila (E)

College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.

Lisa D Auckland (LD)

College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.

Christopher M Roundy (CM)

Department of Entomology, Texas A&M University and AgriLife Research, College Station, TX 77843, USA.

Wendy Tang (W)

Department of Entomology, Texas A&M University and AgriLife Research, College Station, TX 77843, USA.

Mia Kim Torchetti (MK)

National Veterinary Services Laboratories, USDA APHIS VS, Ames, IA 50010, USA.

Mary Lea Killian (ML)

National Veterinary Services Laboratories, USDA APHIS VS, Ames, IA 50010, USA.

Melinda Jenkins-Moore (M)

National Veterinary Services Laboratories, USDA APHIS VS, Ames, IA 50010, USA.

Katie Mozingo (K)

National Veterinary Services Laboratories, USDA APHIS VS, Ames, IA 50010, USA.

Yao Akpalu (Y)

Brazos County Health Department, Bryan, TX 77803, USA.

Ria R Ghai (RR)

National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Jessica R Spengler (JR)

National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Casey Barton Behravesh (C)

National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Rebecca S B Fischer (RSB)

School of Public Health, Texas A&M University, College Station, TX 77843, USA.

Gabriel L Hamer (GL)

Department of Entomology, Texas A&M University and AgriLife Research, College Station, TX 77843, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH